RxSight (RXST) Revenue (2020 - 2026)

RxSight's Revenue history runs 7 years deep, the most recent figure standing at $30.9 million for Q1 2026.

• Quarterly Revenue fell 18.48% year-over-year to $30.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127.5 million (down 14.05% YoY) and the FY2025 annual result came in at $134.5 million, down 3.89% from the prior year.
• Revenue was $30.9 million for Q1 2026 at RxSight, down from $32.6 million in the prior quarter.
• Across five years, Revenue topped out at $40.2 million in Q4 2024 and bottomed at $8.9 million in Q1 2022.
• A 5-year average of $26.1 million and a median of $29.5 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue surged 156.66% — and 2025, when it declined 18.91%.
• RxSight's Revenue stood at $16.1 million in 2022, then jumped by 77.65% to $28.6 million in 2023, then soared by 40.71% to $40.2 million in 2024, then dropped by 18.91% to $32.6 million in 2025, then retreated by 5.26% to $30.9 million in 2026.
• Business Quant data shows RXST's Revenue at $30.9 million in Q1 2026, $32.6 million in Q4 2025, and $30.3 million in Q3 2025.